Abstract:Background: Primary hepatocellular carcinoma (HCC) is a common malignant tumour, and its early symptoms are often not obvious, resulting in many patients experiencing middle- to late-stage disease at the time of diagnosis. The optimal time for surgery is often missed for these patients, and those who do undergo surgery have unsatisfactory long-term outcomes and a high recurrence rate within five years. Therefore, postoperative follow-up treatments, such as transhepatic arterial chemoembolization (TACE), have become critical to improving survival and reducing recurrence rates. Aim: To validate the prophylactic role of TACE after hepatic resection and to assess its impact on patient prognosis. Methods: This study investigated the efficacy of TACE in patients with intermediate-stage HCC after hepatectomy. When the post-treatment results of the observation group and the control group were compared, it was found that the inclusion of TACE significantly improved the clinical efficacy, reduced the levels of tumour markers and did not aggravate the damage to liver function. Thus, this may be an effective and comprehensive treatment strategy for patients with intermediate-stage HCC that helps to improve their quality of life and survival time. Results: When the baseline data were analysed, no statistical differences were found between the two groups in terms of gender, age, hepatitis B virus, cirrhosis, Child-Pugh grading, number of tumours, maximum tumour diameter and degree of tumour differentiation. The assessment of clinical efficacy showed that the post-treatment overall remission rate of the observation group was significantly higher than that of the control group. In terms of changes in tumour markers, the alpha-fetoprotein and carcinoembryonic antigen levels in the patients in the observation group decreased more significantly after treatment compared with those in the control group. When post-treatment changes in liver function indicators were analysed, no statistical differences were found in the total bilirubin, alanine aminotransferase and aspartate aminotransferase levels between the two groups. Conclusion: In patients with intermediate-stage HCC, post-hepatectomy TACE significantly improved clinical outcomes, reduced tumour-marker levels and may have improved the prognosis by removing residual lesions. Thus, this may be an effective and comprehensive treatment strategy for patients with intermediate-stage HCC.

Effect of interventional chemotherapy on cellular immune function and prognosis in elderly patients with primary hepato-cellular carcinoma

Evaluation of the Efficacy for Alternated Treatment on Primary Liver Cancer by Interventional Therapy in Combination with Fractionated Stereotactic Conformal Radiotherapy

Prolong Overall Survival Rate for Patients with Liver Cancer Receiving Double Interventional Therapy

Do Elderly Patients With Stage I-II Hepatocellular Carcinoma Benefit From More Radical Surgeries? A Population-Based Analysis.

Clinical Analysis of the Effect of Contrast-enhanced Ultrasonography on Trans-arterial Chemoembolization for Advanced Liver Cancer in the Elderly

Nonsurgical combination therapy for primary liver cancer in the elderly: analysis of 52 patients

Impact of hepatectomy and postoperative adjuvant transarterial chemoembolization on serum tumor markers and prognosis in intermediate-stage hepatocellular carcinoma

Hepatocellular Carcinoma in Elderly: Clinical Characteristics, Treatments and Outcomes Compared with Younger Adults.

Effect of Yiqi Jiedu traditional Chinese medicine plus transcatheter arterial chemoembolization on primary hepatocellular carcinoma and its influence on T lymphocyte subsets,GP - 73 and GPC - 3 levels

Safety and Effectiveness of Transarterial Chemoembolization in Hepatocellular Carcinoma Patients Aged Greater versus Less Than 80 Years

Factors affecting postoperative prognosis of elderly patients with hepatocellular carcinoma

Impact of Age on the Prognosis after Liver Transplantation for Patients with Hepatocellular Carcinoma: a Single-Center Experience

Survival Analysis of Hepatocellular Carcinoma: A Comparison Between Young Patients and Aged Patients

Clinical Effect and Analysis of Prognostic Factors of the Elder Patients with Hepatocellular Carcinoma Treated by Transcatheter Arterial Chemoembolization

Effect of preoperative infusion chemotherapy combined with hyperthermia on sPD-L1 and CEA levels and overall survival of elderly patients undergoing radical resection of lung cancer

Overall Survival Rates Become Similar Between Percutaneous Ablation and Hepatic Resection with Increasing Age among Elderly Patients with Early Hepatocellular Carcinoma.

Multicenter analysis of long-term oncologic outcomes of hepatectomy for elderly patients with hepatocellular carcinoma

Surgical Treatment of Combined Hepatocellular-Cholangiocarcinoma is As Effective in Elderly Patients As It is in Younger Patients: A Propensity Score Matching Analysis

Prognosis risk factors and therapeutic effect analysis in primary hepatic carcinoma: 394 cases report

Clinical observation of postoperative hepatic arterial infusion and systemic adjuvant chemotherapy in patients with stage Ⅲcolorectal cancer

Clinical outcome in elderly Chinese patients with primary hepatocellular carcinoma treated with percutaneous microwave coagulation therapy (PMCT): A Strobe-compliant observational study.